🇺🇸 FDA
Patent

US 10212923

Humanized dipeptidyl-peptidase IV (DPP4) animals

granted A61PA61P3/10A61P31/12

Quick answer

US patent 10212923 (Humanized dipeptidyl-peptidase IV (DPP4) animals) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P3/10, A61P31/12